Implementation of programs for early detection of type 2 diabetes mellitus and dispensary monitoring of patients with this disease in health care systems: international and national experience

СД – сахарный диабет, ССЗ – сердечно-сосудистые заболевания, HbA1c – гликированный гемоглобин, ПМСП – первичная медико-санитарная помощь, ДН – диспансерное наблюдение, ФР – факторы риска, ИИ – искусственный интеллект, СППВР – системы поддержки принятия врачебных решений, ХНИЗ – хронические неинфекционные заболевания, АД – артериальное давление

1. Dedov I.I., Kontsevaya A.V., Shestakova M.V. et al. Economic costs of type 2 diabetes mellitus and its major cardiovascular complications in the Russian Federation. Diabetes Mellitus. 2016;19(6):518-527. https://doi.org/10.14341/DM8153.

2. Gassner L, Zechmeister-Koss I, Reinsperger I. National Strategies for Preventing and Managing Non-communicable Diseases in Selected Countries. Front Public Health. 2022; 10:838051. doi: 10.3389/fpubh.2022.838051.

3. Gnavi R., Sciannameo V., Baratta F. et al. Opportunistic screening for type 2 diabetes in community pharmacies. Results from a region-wide experience in Italy. PLoS One. 2020;15(3): 1–11. doi: 10.1371/journal.pone.0229842.

4. Hallgren Elfgren I.M., Grodzinsky E., Törnvall E. The Swedish National Diabetes Register in clinical practice and evaluation in primary health care. Primary Health Care Research and Development. 2016;17(6):549-558. doi: 10.1017/S1463423616000098.

5. Risøy A.J., Kjome R.L.S., Sandberg S. et al. Diabetes risk assessments and HbA1c-measurements in community pharmacies. International Journal of Pharmacy Practice. 2023; 31(5):512-519. doi: 10.1093/ijpp/riad055.

6. Riise H.K.R., Graue M., Igland J. et al. Prevalence of increased risk of type 2 diabetes in general practice: a cross-sectional study in Norway. BMC Primary Care. 2023; 24(1):151. doi: 10.1186/s12875-023-02100-x.

7. Hoffman E.D. Jr, Klees B.S., Curtis C.A. Overview of the Medicare and Medicaid Programs. Health Care Financ Rev. 2000; 22 (1):175-193.

8. Knowler W.C., e Barrett-Connor E., Fowler S.E. et al. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. The new England journal of medicine. 2002;346(6):393-403. doi: 10.1056/NEJMoa012512.

9. Wang W. Interpretation of the Diabetes Prevention and Control Action of the Healthy China Initiative 2019-2030. China CDC Wkly. 2020 Feb 28;2(9):143-145. https://pmc.ncbi.nlm.nih.gov/articles/PMC8392887/.

10. Xiong S., Jiang W., Zhang X. et al. Strengthening China’s National Essential Public Health Services Package for hypertension and diabetes care: protocol for an interrupted time series study with mixed-methods process evaluation and health economic evaluation. BMC Public Health 2024; 1–11. doi: 10.1186/s12889-024-20027-5.

11. Kaushal, Kanica. (2018). Indian National Programs and Policy Decisions for Diabetes. Sadikot's International Textbook of Diabetes.

12. Kaur G., Chauhan A.S., Prinja S. et al. Cost-effectiveness of population-based screening for diabetes and hypertension in India: an economic modelling study. The Lancet Public Health. 2022; 7 (1): 65–73. doi: 10.1016/S2468-2667(21)00199-7.

13. Takeuchi M., Shinozaki T, Kawakami K. Effectiveness of Specific Health Check-ups in Japan for the primary prevention of obesity-related diseases: a protocol for a target trial emulation. BMJ Open. 2023;13 (7):1–8. doi:10.1136/bmjopen-2022-070417.

14. Choi J.H., Lee K.A., Moon J.H. et al. 2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association. Diabetes Metabolism Jornal. 2023; 47 (5):575-594. doi: 10.4093/dmj.2023.0282.

15. Collins D, Inglin L, Laatikainen T. et al. Implementing a package of noncommunicable disease interventions in the Republic of Moldova: two-year follow-up data. Prim Health Care Res Dev. 2020; 21: e39. doi: 10.1017/S1463423620000420.

16. Alieva A, Alimov A, Khaidarova F. et al. Assessing the Effectiveness of Type 2 Diabetes Screening in the Republic of Uzbekistan. Int J Endocrinol Metab. 2022; 20(4): e124036. doi: 10.5812/ijem-124036.

17. Drapkina O. M., Mokrysheva N. G., Shestakova M. V. et al. V. et al. Dispensary observation of patients with type 2 diabetes mellitus by a general practitioner in primary health care. Methodological recommendations. Primary Health Care. 2025;2(2):00. doi: 10.15829/10.15829/3034-4123-2025-52. EDN GFIVSG.

18. Manne-Goehler J, Geldsetzer P, Agoudavi K. et al. Health system performance for people with diabetes in 28 low- and middle-income countries: A cross-sectional study of nationally representative surveys. PLoS Med. 2019;16 (3) :e1002751. doi: 10.1371/journal.pmed.1002751.